Promoter holding
64.27%
RL
Rivaara Labs Private Limited - Due diligence report
A 360° intelligence report on Rivaara Labs: trust score, financial health, credit view, compliance, directors, growth and distress signals -…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Rivaara Labs — 360° Intelligence Report
Generated from MCA filings & public records67/100
Trust Score
Moderate
Rivaara Labs is assessed as Moderate with a Trust Score of 67/100. Rivaara Labs is an active private limited indian non-government company incorporated in 2019, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 16 Aug 2026 from the latest processed filings. Rivaara Labs Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
67/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Elevated gearing (D/E 38%).
Charges position: 0 open (-) · 2 satisfied (25.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 2 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VAISHALI NARENDRA RATHOD | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DIVY DANGI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
11 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Genei Laboratories Private Limited | Subsidiary Company | 74.00% |
| Rivaara Inc. | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 60
Growth signals & trust indicators
Revenue acceleration: +1.42 over 2 year(s).
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment45/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events23 Jan 2026
Director ceased
GAUTAM VINOD DAFTARY
31 Oct 2025
Director appointed
DIVY DANGI (Nominee Director)
22 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Nov 2024
Director ceased
VAISHALI NARENDRA RATHOD
28 Mar 2024
Charge satisfied
Hdfc Bank Limited
15 Mar 2023
Director appointed
VAISHALI NARENDRA RATHOD (Company Secretary)
19 Oct 2022
Securities allotted
1 Preference Shares - 31.00 raised
14 Oct 2022
Securities allotted
12902126 Preference Shares - 12.90 cr raised
Securities allotted
3226907 Equity Shares - 3.23 cr raised
31 Mar 2022
Securities allotted
3000000 Equity Shares - 3.00 cr raised
12 Feb 2022
Director ceased
JAWED ZIA
17 Jan 2022
Director ceased
AADITYA ROHAN SHAH
01 May 2021
Director ceased
BHARAT VINOD DAFTARY
Director ceased
SIDDHARTH BHARAT DAFTARY
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 2 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 11 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Millennium Special Lab Private Limited | U85195MH2000PTC128307 | Thane, Maharashtra, India |
| Divine Medical Centre Limited | U85110KL1984PLC003929 | Thrissur, Kerala, India |
| Rajan Dental Institute Private Limited | U85110TN2002PTC048336 | Chennai, Tamil Nadu, India |
| Walron Healthcare Private Limited | U24232RJ2015PTC047350 | Jaipur, Rajasthan, India |
| Smiline Dental Hospital Private Limited | U85110TG2000PTC033267 | Hyderabad, Telangana, India |
| Orchid Cure And Care Private Limited | U85100PN2012PTC144738 | Pune, Maharashtra, India |
| Radion Equipments Private Limited | U74999KA2016PTC098391 | Bangalore, Karnataka, India |
| Anand Diagnostic Laboratory | U85300TN2022PTC148948 | Chennai, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Rivaara Labs before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Rivaara Labs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 80/100, margin trends, ownership structure and peer set for Rivaara Labs - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 67/100, distress signals and MSME payment-delay disclosures - know whether Rivaara Labs pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Rivaara Labs - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Rivaara Labs an active company?
Rivaara Labs has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Rivaara Labs financially healthy?
Rivaara Labs has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Rivaara Labs?
Its overall Trust Score is 67/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Rivaara Labs?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Rivaara Labs have loans or charges against its assets?
No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Rivaara Labs up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Rivaara Labs?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
